Local IL-10 level as a predictive factor in generalized aggressive periodontitis treatment response

Tiago Taiete, Mabelle F Monteiro, Marcio Z Casati, Hugo Felipe do Vale, Glaucia M B Ambosano, Francisco H Nociti, Enilson A Sallum, Renato C V Casarin, Tiago Taiete, Mabelle F Monteiro, Marcio Z Casati, Hugo Felipe do Vale, Glaucia M B Ambosano, Francisco H Nociti, Enilson A Sallum, Renato C V Casarin

Abstract

Generalized aggressive periodontitis (GAgP) presents a reduced response to non-surgical therapy. However, it is not clear if the initial clinical, microbiological or immunological characteristics are impacting the worse response to treatment. This study aimed to identify the predictive value of clinical, microbiological and immunological patterns on the clinical response to therapy in GAgP patients. Twenty-four GAgP patients were selected, and gingival crevicular fluid (GCF) and subgingival biofilm were collected. Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia levels were evaluated by qPCR, and IL-1β and IL-10 concentration by ELISA. Twelve patients were treated with SRP (scaling and root planning), and twelve with SRP plus 375 mg amoxicillin and 250 mg metronidazole (8/8 hours, 7 days) (SRP + AM). The clinical changes (Probing Pocket Depth [PPD] reduction and Clinical Attachment Level [CAL] gain) 6 months post-treatment were correlated to the initial clinical, inflammatory and microbiological variables using stepwise logistic regression (α = 5%). CAL gain at 6 months was 1.16 ± 0.77 for SRP and 1.74 ± 0.57 mm for SRP + AM (P > .05). PPD reduction was 1.96 ± 0.82 for SRP and 2.45 ± 0.77 mm for SRP + AM (P < .05). In the SRP group, IL-10 showed a predictive value for clinical response. The higher the IL-10 concentration at baseline, the higher the reduction in PPD at 6 months (P = .01, r = .68). However, when antimicrobials were administered, no significant influence was detected (P > .05). It can be concluded that the IL-10 levels in GFC act as a predictor of clinical response to GAgP. Moreover, the intake of antimicrobials appears to overlap the influence of the inflammatory response on clinical response to treatment. Clinical trial registration number: NCT03933501.

Keywords: amoxicillin; dental scaling; interleukin-10; metronidazole; periodontal diseases.

© 2019 The Scandinavian Foundation for Immunology.

References

REFERENCES

    1. Tonetti MS, Mombelli A. Early-onset periodontitis. Ann Periodontol. 1999;4:39-53.
    1. Albandar JM, Tinoco E. Global epidemiology of periodontal diseases in children and young persons. Periodontology 2000. 2002;29:153-176.
    1. Susin C, Albandar JM. Aggressive periodontitis in an Urban population in Southern Brazil. J Periodontol. 2005;76:468-475. Available from
    1. Susin C, Haas AN, Albandar JM. Epidemiology and demographics of aggressive periodontitis. Periodontology 2000. 2014;65:27-45.
    1. Slots J, Rosling BG. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol. 1983;10:465-486. Available from
    1. Christersson LA, Slots J, Rosling BG, Genco RJ. Microbiological and clinical effects of surgical treatment of localized juvenile periodontitis. J Clin Periodontol. 1985;12:465-476. Available from .
    1. Deas DE, Mealey BL. Response of chronic and aggressive periodontitis to treatment. Periodontology 2000. 2010;53:154-166.
    1. Scharf S, Wohlfeil M, Siegelin Y, Schacher B, Dannewitz B, Eickholz P. Clinical results after nonsurgical therapy in aggressive and chronic periodontitis. Clin Oral Investig. 2014;18:453-460. Available from .
    1. Teughels W, Dhondt R, Dekeyser C, Quirynen M. Treatment of aggressive periodontitis. Periodontology 2000. 2014;65:107-133.
    1. Guerrero A, Griffiths GS, Nibali L, et al. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2005;32:1096-1107. Available from
    1. Matarese G, Ramaglia L, Fiorillo L, Cervino G, Lauritano F, Isola G. Implantology and periodontal disease: the panacea to problem solving? Open Dent J. 2017;11:460-465. Available from
    1. Meyer-Bäumer A, Pritsch M, Cosgarea R, et al. Prognostic value of the periodontal risk assessment in patients with aggressive periodontitis. J Clin Periodontol. 2012;39:651-658. Available from
    1. Lang NP, Tonetti MS. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent. 2003;1:7-16. Available from
    1. Lü D, Meng H, Xu L, et al. New attempts to modify periodontal risk assessment for generalized aggressive periodontitis: a retrospective study. J Periodontol. 2013;84(11):1536-45.
    1. Haas AN, Silva-boghossian CM, Colombo AP, et al. Predictors of clinical outcomes after periodontal treatment of aggressive periodontitis: 12-month randomized trial. Braz Oral Res 2016;30(1).
    1. Briguglio F, Briguglio E, Briguglio R, Cafiero C, Isola G. Treatment of infrabony periodontal defects using a resorbable biopolymer of hyaluronic acid: a randomized clinical trial. Quintessence Int. 2013;44:231-240. Available from .
    1. Cortelli JR, Cortelli SC, Jordan S, Haraszthy VI, Zambon JJ. Prevalence of periodontal pathogens in Brazilians with aggressive or chronic periodontitis. J Clin Periodontol. 2005;32:860-866.
    1. Gajardo M, Silva N, Gómez L, et al. Prevalence of periodontopathic bacteria in aggressive periodontitis patients in a Chilean population. J Periodontol. 2005;76:289-294. Available from .
    1. Casarin R, Del Peloso RÉ, Mariano FS, Nociti FH, Casati MZ, Gonçalves RB. Levels of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, inflammatory cytokines and species-specific immunoglobulin G in generalized aggressive and chronic periodontitis. J Periodontal Res. 2010;45:635-642.
    1. Könönen E, Müller HP. Microbiology of aggressive periodontitis. Periodontology 2000. 2014;65:46-78.
    1. Faveri M, Mayer M, Feres M, de Figueiredo LC, Dewhirst FE, Paster BJ. Microbiological diversity of generalized aggressive periodontitis by 16S rRNA clonal analysis. Oral Microbiol Immunol. 2008;23:112-118.
    1. Bastos MF, Lima JA, Vieira PM, Mestnik MJ, Faveri M, Duarte PM. TNF-alpha and IL-4 levels in generalized aggressive periodontitis subjects. Oral Dis. 2009;15:82-87. Available from:
    1. Taiete T, Casarin RCV, Ruiz KGS, et al . Transcriptome of healthy gingival tissue from edentulous sites in patients with a history of generalized aggressive periodontitis. J Periodontol. 2018;89(1):93-104.
    1. Taiete T, Casati MZ, Stolf CS, et al. Validation of reported GLT6D1 (rs1537415), IL10 (rs6667202), and ANRIL (rs1333048) single nucleotide polymorphisms for aggressive periodontitis in a Brazilian population. J Periodontol. 2019;90:44-51. Available from
    1. Casarin R, Peloso Ribeiro ED, Sallum EA, Nociti FH, Gonçalves RB, Casati MZ. The combination of amoxicillin and metronidazole improves clinical and microbiologic results of one-stage, full-mouth, ultrasonic debridement in aggressive periodontitis treatment. J Periodontol. 2012;83:988-998. Available from
    1. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25:229-235.
    1. Mühlemann H, Son S. Gingival sulcus bleeding-a leading symptom in initial gingivitis. Helv Odontol Acta. 1971;15:107-113.
    1. Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol. 2001;28:296-305.
    1. Del Peloso RÉ, Bittencourt S, Sallum EA, Nociti FH, Gonçalves RB, Casati MZ. Periodontal debridement as a therapeutic approach for severe chronic periodontitis: a clinical, microbiological and immunological study. J Clin Periodontol. 2008;35:789-798. Available from .
    1. Mattuella LG, Campagnaro MB, Vargas AE, et al. Plasma cytokines levels in aggressive and chronic periodontitis. Acta Odontol Scand. 2013;71:683-688. Available from
    1. Teles RP, Gursky LC, Faveri M, et al. Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis. J Clin Periodontol. 2010;37:313-323. Available from:
    1. Garlet GP, Martins W, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res. 2003;38:210-217.
    1. Luo Y, Gong Y, Yu Y. Interleukin-10 gene promoter polymorphisms are associated with cyclosporin A-induced gingival overgrowth in renal transplant patients. Arch Oral Biol. 2013;58:1199-1207. Available from
    1. Reichert S, Machulla H, Klapproth J, et al. The interleukin-10 promoter haplotype ATA is a putative risk factor for aggressive periodontitis. J Periodontal Res. 2007;0:070521022335002. Available from:
    1. Houri-Haddad Y, Soskolne WA, Halabi A, Shapira L. IL-10 gene transfer attenuates P. gingivalis-induced inflammation. J Dent Res. 2007;86:560-564. Available from:
    1. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205-218. Available from
    1. Marinou I, Healy J, Mewar D, et al. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum. 2007;56:2549-2556. Available from
    1. Wieten L, Berlo SE, ten Brink CB, et al. IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS One. 2009;4:e4186.
    1. Carmody EE, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum. 2002;46:1298-1308. Available from
    1. Al-Rasheed A, Scheerens H, Rennick DM, Fletcher HM, Tatakis DN. Accelerated alveolar bone loss in mice lacking interleukin-10. J Dent Res. 2003;82:632-635. Available from
    1. Lee SF, Andrian E, Rowland E, Marquez IC. Immune response and alveolar bone resorption in a mouse model of Treponema denticola infection. Infect Immun. 2009;77:694-698. Available from
    1. Leppilahti JM, Kallio MA, Tervahartiala T, Sorsa T, Mäntylä P. Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis. J Periodontol. 2014;85:250-260. Available from
    1. Simonson LG, Robinson PJ, Pranger RJ, Cohen ME, Morton HE. Treponema denticola and Porphyromonas gingivalis as prognostic markers following periodontal treatment. J Periodontol. 1992;63:270-273. Available from
    1. Kaner D, Bernimoulin J-P, Dietrich T, Kleber B-M, Friedmann A. Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis. J Periodontal Res. 2011;46:417-426. Available from
    1. Allin N, Cruz-Almeida Y, Velsko I, et al. Inflammatory response influences treatment of localized aggressive periodontitis. J Dent Res. 2016;95:635-641. Available from
    1. Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol. 2012;39:284-294. Available from
    1. Mestnik MJ, Feres M, Figueiredo LC, et al. The effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized aggressive periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2012;39:955-961. Available from
    1. Taiete T, Casati MZ, Ribeiro ÉDP, Sallum EA, Nociti Júnior FH, Casarin R. Amoxicillin/metronidazole associated with nonsurgical therapy did not promote additional benefits in immunologic parameters in generalized aggressive periodontitis: a randomized controlled clinical trial. Quintessence Int. 2016;47:281-292. Available from
    1. Andere N, Castro dos Santos NC, Araujo CF, et al. Clarithromycin as an adjunct to one-stage full-mouth ultrasonic periodontal debridement in generalized aggressive periodontitis: a randomized controlled clinical trial. J Periodontol. 2017;88:1244-1252.
    1. Papapanou PN, Behle JH, Kebschull M, et al. Subgingival bacterial colonization profiles correlate with gingival tissue gene expression. BMC Microbiol. 2009;9:221. Available from:
    1. Kato T, Okuda K. Actinobacillus actinomycetemcomitans possesses an antigen binding to anti-human IL-10 antibody. FEMS Microbiol Lett. 2001;204:293-297. Available from
    1. Azoubel M, Sarmento VA, Cangussú V, et al. Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation. J Periodontol. 2008;79:1719-1725. Available from
    1. Becerik S, Afacan B, Oztürk VÖ, Atmaca H, Emingil G. Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-terminal telopeptid levels in health and different periodontal diseases. Dis Markers. 2011;31:343-352. Available from
    1. Becerik S, Öztürk VÖ, Celec P, Kamodyova N, Atilla G, Emingil G. Gingival crevicular fluid and plasma oxidative stress markers and TGM-2 levels in chronic periodontitis. Arch Oral Biol. 2017;83:47-54. Available from

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner